Melatonin does not produce sedation in rats: A chronobiological study

References

• Acil M, Basgul E, Celiker V, Karagöz AH, Demir B, Aypar U. 2004. Perioperative effects of melatonin and midazolam premedication on sedation, orientation, anxiety scores and psychomotor performance. Eur J Anaesthesiol. 21(7):553–557. doi: 10.1017/S0265021504007094.
   PubMed Web of Science ®Google Scholar
• Andersen LP. 2016. The analgesic effects of exogenous melatonin in humans. Dan Med J. 63(10):B5289.
   PubMed Web of Science ®Google Scholar
• Ansari G, Fathi M, Ghajari MF, Bargrizan M, Eghbali A. 2018. Oral melatonin versus midazolam as premedication for intravenous sedation in pediatric dental patients. J Dent (Tehran). 15(5):317–324.
   PubMedGoogle Scholar
• Antón-Tay F, Díaz JL, Fernández-Guardiola A. 1971. On the effect of melatonin upon human brain. Its possible therapeutic implications. Life Sci. 10(15):841–850. doi: 10.1016/0024-3205(71)90155-X.
   Google Scholar
• Bahna SG, Niles LP. 2018. Epigenetic regulation of melatonin receptors in neuropsychiatric disorders. Br J Pharmacol. 175(16):3209–3219. doi: 10.1111/bph.v175.16.
   PubMed Web of Science ®Google Scholar
• Bilu C, Kronfeld-Schor N. 2013. Effects of circadian phase and melatonin injection on anxiety-like behavior in nocturnal and diurnal rodents. Chronobiol Int. 30(6):828–836. doi: 10.3109/07420528.2013.773439.
   PubMed Web of Science ®Google Scholar
• Borazan H, Tuncer S, Yalcin N, Erol A, Otelcioglu S. 2010. Effects of preoperative oral melatonin medication on postoperative analgesia, sleep quality, and sedation in patients undergoing elective prostatectomy: a randomized clinical trial. J Anesth. 24(2):155–160. doi: 10.1007/s00540-010-0891-8.
   PubMed Web of Science ®Google Scholar
• Brotto LA, Barr AM, Gorzalka BB. 2000. Sex differences in forced-swim and open-field test behaviours after chronic administration of melatonin. Eur J Pharmacol. 402(1–2):87–93. doi: 10.1016/S0014-2999(00)00491-X.
   PubMed Web of Science ®Google Scholar
• Buscemi N, Vandermeer B, Hooton N, Pandya R, Tjosvold L, Hartling L, Baker G, Klassen TP, Vohra S. 2005. The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis. J Gen Intern Med. 20(12):1151–1158. doi: 10.1111/j.1525-1497.2005.0243.x.
   PubMed Web of Science ®Google Scholar
• Capuzzo M, Zanardi B, Schiffino E, Buccoliero C, Gragnaniello D, Bianchi S, Alvisi R. 2006. Melatonin does not reduce anxiety more than placebo in the elderly undergoing surgery. Anesth Analg. 103(1):121–123. doi: 10.1213/01.ane.0000222476.62547.ed.
   PubMed Web of Science ®Google Scholar
• Chamblin MH 1973. Melatonin: an assessment of a possible role in the induction and maintenance of sleep in the normal and parachlorophenylalanine treated cat. Diss Abstr Int. B33: 4535.
   Google Scholar
• Corrales A, Martínez P, García S, Vidal V, García E, Flórez J, Sanchez-Barceló EJ, Martínez-Cué C, Rueda N. 2013. Long-term oral administration of melatonin improves spatial learning and memory and protects against cholinergic degeneration in middle-aged Ts65Dn mice, a model of Down syndrome. J Pineal Res. 54(3):346–358. doi: 10.1111/jpi.2013.54.issue-3.
   PubMed Web of Science ®Google Scholar
• Corthell JT, Stathopoulos AM, Watson CC, Bertram R, Trombley PQ. 2013. Olfactory bulb monoamine concentrations vary with time of day. Neuroscience. 247:234–241. doi: 10.1016/j.neuroscience.2013.05.040.
   PubMed Web of Science ®Google Scholar
• Deacon RM. 2013. Measuring motor coordination in mice. J Vis Exp. 29:e2609. doi: 10.3791/2609.
   Google Scholar
• Dinh QT, Cryer A, Dinh S, Peiser C, Wu S, Springer J, Hamelmann E, Klapp BF, Heppt W, Fischer A. 2005. Transcriptional up-regulation of histamine receptor-1 in epithelial, mucus and inflammatory cells in perennial allergic rhinitis. Clin Exp Allergy. 35(11):1443–1448. doi: 10.1111/cea.2005.35.issue-11.
   PubMed Web of Science ®Google Scholar
• Dubocovich ML, Markowska M. 2005. Functional MT1 and MT2 melatonin receptors in mammals. Endocrine. 27(2):101–110. doi: 10.1385/ENDO:27:2.
   PubMed Web of Science ®Google Scholar
• Eison AS, Freeman RP, Guss VB, Mullins UL, Wright RN. 1995. Melatonin agonists modulate 5-HT2A receptor-mediated neurotransmission: behavioral and biochemical studies in the rat. J Pharmacol Exp Ther. 273(1):304–308.
   PubMed Web of Science ®Google Scholar
• Esteban S, Garau C, Aparicio S, Moranta D, Barceló P, Fiol MA, Rial R. 2010. Chronic melatonin treatment and its precursor L-tryptophan improve the monoaminergic neurotransmission and related behavior in the aged rat brain. J Pineal Res. 48(2):170–177. doi: 10.1111/jpi.2010.48.issue-2.
   PubMed Web of Science ®Google Scholar
• Faghihian R, Eshghi A, Faghihian H, Kaviani N. 2018. Comparison of oral melatonin and midazolam as premedication in children undergoing general anesthesia for dental treatment. Anesth Pain Med. 8(2):e64236. doi: 10.5812/aapm.
   PubMedGoogle Scholar
• Fagiolini A, Comandini A, Dell’Osso MC, Kasper S. 2012. Rediscovering trazodone for the treatment of major depressive disorder. CNS Drugs. 26:1033–1049. doi: 10.1007/s40263-012-0010-5.
   PubMed Web of Science ®Google Scholar
• Fallah R, Yadegari Y, Behdad S, Akhavan Karbasi S. 2014. Melatonin and intravenous midazolam administered orally in drug induced sleep electroencephalography of children: randomized clinical trial of efficacy. Arch Iran Med. 17(11):741–745.
   PubMed Web of Science ®Google Scholar
• Gitto E, Marseglia L, D’Angelo G, Manti S, Crisafi C, Montalto AS, Impellizzeri P, Reiter RJ, Romeo C. 2016. Melatonin versus midazolam premedication in children undergoing surgery: A pilot study. J Pediatric Child Health. 52(3):291–295. doi: 10.1111/jpc.13007.
   PubMed Web of Science ®Google Scholar
• Gomaa AM, Galal HM, Abou-Elgait AT. 2017. Neuroprotective effects of melatonin administration against chronic immobilization stress in rats. Int J Physiol Pathophysiol Pharmacol. 9(2):16–27.
   PubMedGoogle Scholar
• Gorzalka BB, Brotto LA, Hong JJ. 1999. Corticosterone regulation of 5-HT2A receptor-mediated behaviors: attenuation by melatonin. Physiol Behav. 67(3):439–442. doi: 10.1016/S0031-9384(99)00096-7.
   PubMed Web of Science ®Google Scholar
• Graw P, Werth E, Kräuchi K, Gutzwiller F, Cajochen C, Wirz-Justice A. 2001. Early morning melatonin administration impairs psychomotor vigilance. Behav Brain Res. 121(1–2):167–172. doi: 10.1016/S0166-4328(01)00158-9.
   PubMed Web of Science ®Google Scholar
• Hansen MV, Halladin NL, Rosenberg J, Gögenur I, Møller AM. 2015. Melatonin for pre- and postoperative anxiety in adults. Cochrane Database Syst Rev. 2015 (4):CD009861. doi: 10.1002/14651858.CD009861.pub2.
   PubMed Web of Science ®Google Scholar
• Hardeland R, Poeggeler B, Srinivasan V, Trakht I, Pandi-Perumal SR, Cardinali DP. 2008. Melatonergic drugs in clinical practice. Arzneimittelforschung. 58(1):1–10. doi: 10.1055/s-0031-1296459.
   PubMed Web of Science ®Google Scholar
• Hattori M, Mizuguchi H, Baba Y, Ono S, Nakano T, Zhang Q, Sasaki Y, Kobayashi M, Kitamura Y, Takeda N, et al. 2013. Quercetin inhibits transcriptional up-regulation of histamine H1 receptor via suppressing protein kinase C-δ/extracellular signal-regulated kinase/poly(ADP-ribose) polymerase-1 signaling pathway in HeLa cells. Int Immunopharmacol. 15(2):232–239. doi: 10.1016/j.intimp.2012.12.030.
   PubMed Web of Science ®Google Scholar
• Holmes SW, Sugden D. 1982. Effects of melatonin on sleep and neurochemistry in the rat. Br J Pharmacol. 76(1):95–101. doi: 10.1111/bph.1982.76.issue-1.
   PubMed Web of Science ®Google Scholar
• Huang F, Yang Z, Li CQ. 2017. The melatonergic system in anxiety disorders and the role of melatonin in conditional fear. Vitam Horm. 103(2):281–294.
   PubMedGoogle Scholar
• Hulihan-Giblin BA, Pivorun EB, Goldman D. 1993. Diurnal rhythms of 5-HT1A and 5-HT2 receptor binding in euthermic and torpor prone deer mice, Peromyscus maniculatus. Pharmacol Biochem Behav. 45(4):785–789. doi: 10.1016/0091-3057(93)90121-9.
   PubMed Web of Science ®Google Scholar
• Impellizzeri P, Vinci E, Gugliandolo MC, Cuzzocrea F, Larcan R, Russo T, Gravina MR, Arena S, D’Angelo G, Gitto E, et al. 2017. Premedication with melatonin vs midazolam: efficacy on anxiety and compliance in paediatric surgical patients. Eur J Pediatr. 176(7):947–953. doi: 10.1007/s00431-017-2933-9.
   PubMed Web of Science ®Google Scholar
• Islam R, Mizuguchi H, Shaha A, Nishida K, Yabumoto M, Ikeda H, Fujino H, Kitamura Y, Fukui H, Takeda N. 2018. Effect of wild grape on the signaling of histamine H1 receptor gene expression responsible for the pathogenesis of allergic rhinitis. J Med Invest. 65(3.4):242–250. doi: 10.2152/jmi.65.242.
   PubMed Web of Science ®Google Scholar
• Iwase M, Ohshima Y, Izumizaki M, Homma I. 2010. Circadian changes in respiratory responses to acute hypoxia and histamine H1 receptors in mice. Adv Exp Med Biol. 669:235–238.
   PubMed Web of Science ®Google Scholar
• Jawed S, Kim B, Ottenhof T, Brown GM, Werstiuk ES, Niles LP. 2007. Human melatonin MT1 receptor induction by valproic acid and its effects in combination with melatonin on MCF-7 breast cancer cell proliferation. Eur J Pharmacol. 560(1):17–22. doi: 10.1016/j.ejphar.2007.01.022.
   PubMed Web of Science ®Google Scholar
• Jockers R, Delagrange P, Dubocovich ML, Markus RP, Renault N, Tosini G, Cecon E, Zlotos DP. 2016. Update on melatonin receptors: IUPHAR Review 20. Br J Pharmacol. 173(18):2702–2725. doi: 10.1111/bph.13536.
   PubMed Web of Science ®Google Scholar
• Kamal M, Gbahou F, Guillaume J-L, Daulat AM, Benleulmi-Chaachoua A, Luka M, Chen P, Kalbasi Anaraki D, Baroncini M, Mannoury la Cour C, et al. 2015. Convergence of melatonin and serotonin (5-HT) signaling at MT2/5-HT2C receptor heteromers. J Biol Chem. 290(18):11537–11546. doi: 10.1074/jbc.M114.559542.
   PubMed Web of Science ®Google Scholar
• Kurdi MS, Muthukalai SP. 2016. A comparison of the effect of two doses of oral melatonin with oral midazolam and placebo on pre-operative anxiety, cognition and psychomotor function in children: A randomised double-blind study. Indian J Anaesth. 60(10):744–750. doi: 10.4103/0019-5049.191688.
   PubMed Web of Science ®Google Scholar
• Kurdi MS, Patel T. 2013. The role of melatonin in anaesthesia and critical care. Indian J Anaesth. 57(2):137–144. doi: 10.4103/0019-5049.111837.
   PubMedGoogle Scholar
• Lemmer B. 1994. Chronopharmacology: time, a key in drug treatment. Ann Biol Clin (Paris). 52(1):1–7.
   PubMed Web of Science ®Google Scholar
• Lemmer B. 2000. Relevance for chronopharmacology in practical medicine. Semin Perinatol. 24(4):280–290. doi: 10.1053/sper.2000.8595.
   PubMed Web of Science ®Google Scholar
• Lewis SR, Pritchard MW, Schofield-Robinson OJ, Alderson P, Smith AF. 2018. Melatonin for the promotion of sleep in adults in the intensive care unit. Cochrane Database Syst Rev. 5:CD012455. doi: 10.1002/14651858.CD012454.pub2.
   PubMedGoogle Scholar
• Liet C, Amenouche F, Freret T, Boulouard M, Mauvieux B, Lelong-Boulouard V, Bocca M-L. 2015. Effects of acute administration of melatonin on attentional, executive, and working memory processes in rats. Fundam Clin Pharmacol. 29(5):472–477. doi: 10.1111/fcp.12134.
   PubMed Web of Science ®Google Scholar
• Liu J, Clough SJ, Hutchinson AJ, Adamah-Biassi EB, Popovska-Gorevski M, Dubocovich ML. 2016. MT1 and MT2 melatonin receptors: a therapeutic perspective. Annu Rev Pharmacol Toxicol. 56:361–383. doi: 10.1146/annurev-pharmtox-010814-124742.
   PubMed Web of Science ®Google Scholar
• Marks V, English J, Aherne W, Arendt J. 1985. Chronopharmacology. Clin Biochem. 18(3):154–157. doi: 10.1016/S0009-9120(85)80100-4.
   PubMed Web of Science ®Google Scholar
• Marseglia L, D’Angelo G, Manti S, Aversa S, Arrigo T, Reiter RJ, Gitto E. 2015. Analgesic, anxiolytic and anaesthetic effects of melatonin: new potential uses in pediatrics. Int J Mol Sci. 16(1):1209–1220. doi: 10.3390/ijms16011209.
   PubMed Web of Science ®Google Scholar
• Mendelson WB. 1997. A critical evaluation of the hypnotic efficacy of melatonin. Sleep. 20(10):916–919. doi: 10.1093/sleep/20.10.916.
   PubMed Web of Science ®Google Scholar
• Mendelson WB, Gillin JC, Dawson SD, Lewy AJ, Wyatt RJ. 1980. Effects of melatonin and propranolol on sleep of the rat. Brain Res. 201(1):240–244. doi: 10.1016/0006-8993(80)90793-3.
   PubMed Web of Science ®Google Scholar
• Miyoshi K, Kawakami N, Das AK, Fujimoto K, Horio S, Fukui H. 2007. Heterologous up-regulation of the histamine H1 receptor by M3 muscarinic receptor-mediated activation of H1-receptor gene transcription. J Pharm Pharmacol. 59(6):843–848. doi: 10.1211/jpp.59.6.0010.
   PubMed Web of Science ®Google Scholar
• Mizuguchi H, Miyagi K, Terao T, Sakamoto N, Yamawaki Y, Adachi T, Ono S, Sasaki Y, Yoshimura Y, Kitamura Y, et al. 2012. PMA-induced dissociation of Ku86 from the promoter causes transcriptional up-regulation of histamine H1 receptor. Sci Rep. 2:916. doi: 10.1038/srep00916.
   PubMed Web of Science ®Google Scholar
• Mizuguchi H, Terao T, Kitai M, Ikeda M, Yoshimura Y, Das AK, Kitamura Y, Takeda N, Fukui H. 2011. Involvement of protein kinase Cδ/extracellular signal-regulated kinase/poly(ADP-ribose) polymerase-1 (PARP-1) signaling pathway in histamine-induced up-regulation of histamine H1 receptor gene expression in HeLa cells. J Biol Chem. 286(35):30542–30551. doi: 10.1074/jbc.M111.253104.
   PubMed Web of Science ®Google Scholar
• Mochizuki T, Yamatodani A, Okakura K, Horii A, Inagaki N, Wada H. 1992. Circadian rhythm of histamine release from the hypothalamus of freely moving rats. Physiol Behav. 51(2):391–394. doi: 10.1016/0031-9384(92)90157-W.
   PubMed Web of Science ®Google Scholar
• Naguib M, Hammond DL, Schmid PG 3rd, Baker MT, Cutkomp J, Queral L, Smith T. 2003a. Pharmacological effects of intravenous melatonin: comparative studies with thiopental and propofol. Br J Anaesth. 90(4):504–507. doi: 10.1093/bja/aeg092.
   PubMed Web of Science ®Google Scholar
• Naguib M, Samarkandi AH. 1999. Premedication with melatonin: a double-blind, placebo-controlled comparison with midazolam. Br J Anaesth. 82(6):875–880. doi: 10.1093/bja/82.6.875.
   PubMed Web of Science ®Google Scholar
• Naguib M, Samarkandi AH. 2000. The comparative dose-response effects of melatonin and midazolam for premedication of adult patients: a double-blinded, placebo-controlled study. Anesth Analg. 91(2):473–479. doi: 10.1097/00000539-200008000-00046.
   PubMed Web of Science ®Google Scholar
• Naguib M, Samarkandi AH, Moniem MA, Eel-D M, Alshaer AA, Al-Ayyaf HA, Fadin A, Alharby SW. 2006. The effects of melatonin premedication on propofol and thiopental induction dose-response curves: a prospective, randomized, double-blind study. Anesth Analg. 103(6):1448–1452. doi: 10.1213/01.ane.0000244534.24216.3a.
   PubMed Web of Science ®Google Scholar
• Naguib M, Schmid PG 3rd, Baker MT. 2003b. The electroencephalographic effects of IV anesthetic doses of melatonin: comparative studies with thiopental and propofol. Anesth Analg. 97(1):238–243. doi: 10.1213/01.ANE.0000065545.58026.23.
   PubMed Web of Science ®Google Scholar
• Niles LP, Sathiyapalan A, Bahna S, Kang NH, Pan Y. 2012. Valproic acid up-regulates melatonin MT1 and MT2 receptors and neurotrophic factors CDNF and MANF in the rat brain. Int J Neuropsychopharmacol. 15(9):1343–1350. doi: 10.1017/S1461145711001969.
   PubMed Web of Science ®Google Scholar
• Norouzi A, Fateh S, Modir H, Kamali A, Akrami L. 2019. Premedication effect of melatonin on propofol induction dose for anesthesia, anxiety, orientation and sedation after abdominal surgery: a double-blinded randomized trial. Med Gas Res. 9(2):62–67. doi: 10.4103/2045-9912.260646.
   PubMed Web of Science ®Google Scholar
• Ohshima Y, Iwase M, Izumizaki M, Kanamaru M, Homma I. 2008. Time-dependent ventilatory response to poikilocapnic hypoxia during light and dark periods and the role of histamine H1 receptors in mice. J Physiol Sci. 58(2):147–150. doi: 10.2170/physiolsci.SC002408.
   PubMed Web of Science ®Google Scholar
• Oishi A, Cecon E, Jockers R. 2018. Melatonin receptor signaling: impact of receptor oligomerization on receptor function. Int Rev Cell Mol Biol. 338:59–77.
   PubMed Web of Science ®Google Scholar
• Oishi A, Karamitri A, Gerbier R, Lahuna O, Ahmad R, Jockers R. 2017. Orphan GPR61, GPR62 and GPR135 receptors and the melatonin MT2 receptor reciprocally modulate their signaling functions. Sci Rep. 7(1):8990. doi: 10.1038/s41598-017-08996-7.
   PubMedGoogle Scholar
• Onaolapo OJ, Onaolapo AY. 2018. Melatonin in drug addiction and addiction management: exploring an evolving multidimensional relationship. World J Psychiatry. 8(2):64–74. doi: 10.5498/wjp.v8.i2.64.
   PubMed Web of Science ®Google Scholar
• Pandi-Perumal SR, Trakht I, Spence DW, Srinivasan V, Dagan Y, Cardinali DP. 2008. The roles of melatonin and light in the pathophysiology and treatment of circadian rhythm sleep disorders. Nat Clin Pract Neurol. 4(8):436–447. doi: 10.1038/ncpneuro0847.
   PubMedGoogle Scholar
• Pasini AM, Marjanović J, Roić G, Dukarić N, Tripalo Batoš A, Bahtijarević Z, Gagro A. 2018. Melatonin as an alternative sedation method during magnetic resonance imaging in preschool children with musculoskeletal problems. Eur J Pediatr. 177(9):1359–1362. doi: 10.1007/s00431-017-3069-7.
   PubMed Web of Science ®Google Scholar
• Patel T, Kurdi MS. 2015. A comparative study between oral melatonin and oral midazolam on preoperative anxiety, cognitive, and psychomotor functions. J Anaesthesiol Clin Pharmacol. 31(1):37–43. doi: 10.4103/0970-9185.150534.
   PubMedGoogle Scholar
• Peña IJ, Hong E, Kim HJ, de la Peña JB, Woo TS, Lee YS, Cheong JH. 2015. Artemisia capillaris Thunberg produces sedative-hypnotic effects in mice, which are probably mediated through potentiation of the GABA(A) receptor. Am J Chin Med. 28:1–13.
   Google Scholar
• Phillips JE. 2017. Inhaled efficacious dose translation from rodent to human: A retrospective analysis of clinical standards for respiratory diseases. Pharmacol Ther. 178:141–147. doi: 10.1016/j.pharmthera.2017.04.003.
   PubMed Web of Science ®Google Scholar
• Pinato L, Ramos D, Hataka A, Rossignoli PS, Granado MD Jr., Mazzetto MC, Campos LMG. 2017. Day/night expression of MT(1) and MT(2) receptors in hypothalamic nuclei of the primate Sapajus apella. J Chem Neuroanat. 81:10–17. doi: 10.1016/j.jchemneu.2017.01.005.
   PubMed Web of Science ®Google Scholar
• Prast H, Saxer A, Philippu A. 1988. Pattern of in vivo release of endogenous histamine in the mamillary body and the amygdala. Naunyn Schmiedebergs Arch Pharmacol. 337(1):53–57. doi: 10.1007/BF00169476.
   PubMed Web of Science ®Google Scholar
• Reagan-Shaw S, Nihal M, Ahmad N. 2008. Dose translation from animal to human studies revisited. Faseb J. 22(3):659–661. doi: 10.1096/fj.07-9574LSF.
   PubMed Web of Science ®Google Scholar
• Rebai R, Jasmin L, Boudah A. 2017. The antidepressant effect of melatonin and fluoxetine in diabetic rats is associated with a reduction of the oxidative stress in the prefrontal and hippocampal cortices. Brain Res Bull. 134(1):142–150. doi: 10.1016/j.brainresbull.2017.07.013.
   PubMedGoogle Scholar
• Rinaldi-Carmona M, Bouaboula M, Congy C, Oury-Donat F, Simiand J, Shire D, Casellas P, Soubrié P, Brelière J-C, Le Fur G. 1993. Up-regulation of 5-HT2 receptors in the rat brain by repeated administration of SR 46349B, a selective 5-HT2 receptor antagonist. Eur J Pharmacol. 246(1):73–80. doi: 10.1016/0922-4106(93)90012-X.
   PubMed Web of Science ®Google Scholar
• Rozov SV, Zant JC, Karlstedt K, Porkka-Heiskanen T, Panula P. 2014. Periodic properties of the histaminergic system of the mouse brain. Eur J Neurosci. 39(2):218–228. doi: 10.1111/ejn.2014.39.issue-2.
   PubMed Web of Science ®Google Scholar
• Sack RL, Hughes RJ, Edgar DM, Lewy AJ. 1997. Sleep-promoting effects of melatonin: at what dose, in whom, under what conditions, and by what mechanisms? Sleep. 20(10):908–915. doi: 10.1093/sleep/20.10.908.
   PubMed Web of Science ®Google Scholar
• Salazar-Juárez A, Barbosa-Méndez S, Jurado N, Hernández-Miramontes R, Leff P, Antón B. 2016. Mirtazapine prevents induction and expression of cocaine-induced behavioral sensitization in rats. Prog Neuropsychopharmacol Biol Psychiatry. 68(1):15–24. doi: 10.1016/j.pnpbp.2016.02.010.
   PubMedGoogle Scholar
• Salazar-Juárez A, Barbosa-Méndez S, Merino-Reyes P, Matus-Ortega M, Hernández-Calderón JA, Antón B. 2017. Chronic dosing with mirtazapine does not produce sedation in rats. Braz J Psychiatry. 39(3):228–236. doi: 10.1590/1516-4446-2016-2058.
   PubMedGoogle Scholar
• Samarkandi A, Naguib M, Riad W, Thalaj A, Alotibi W, Aldammas F, Albassam A. 2005. Melatonin vs. midazolam premedication in children: a double-blind. Eur J Anaesthesiol. 22(3):189–196. doi: 10.1017/S0265021505000335.
   PubMed Web of Science ®Google Scholar
• Shavali S, Ho B, Govitrapong P, Sawlom S, Ajjimaporn A, Klongpanichapak S, Ebadi M. 2005. Melatonin exerts its analgesic actions not by binding to opioid receptor subtypes but by increasing the release of β-endorphin an endogenous opioid. Brain Res Bull. 64(6):471–479. doi: 10.1016/j.brainresbull.2004.09.008.
   PubMed Web of Science ®Google Scholar
• Sircar R. 2000 Feb 28. Effect of melatonin on cocaine-induced behavioral sensitization. Brain Res. 857(1–2):295–299. doi:10.1016/S0006-8993(99)02460-9.
   PubMed Web of Science ®Google Scholar
• Spasojevic N, Stefanovic B, Jovanovic P, Dronjak S. 2016. Anxiety and hyperlocomotion induced by chronic unpredictable mild stress can be moderated with melatonin treatment. Folia Biol (Praha). 62(6):250–257.
   PubMed Web of Science ®Google Scholar
• Srikiatkhachorn A, Govitrapong P, Limthavon C. 1994. Up-regulation of 5-HT2 serotonin receptor: a possible mechanism of transformed migraine. Headache. 34(1):8–11. doi: 10.1111/hed.1994.34.issue-1.
   PubMed Web of Science ®Google Scholar
• Stahl SM. 2009. Mechanism of action of trazodone: a multifunctional drug. CNS Spectr. 14:536–546. doi: 10.1017/S1092852900024020.
   PubMed Web of Science ®Google Scholar
• Stone BM, Turner C, Mills SL, Nicholson AN. 2000. Hypnotic activity of melatonin. Sleep. 23(5):1–7. doi: 10.1093/sleep/23.5.1i.
   Web of Science ®Google Scholar
• Suhner A, Schlagenhauf P, Tschopp A, Hauri-Bionda R, Friedrich-Koch A, Steffen R. 1998. Impact of melatonin on driving performance. J Travel Med. 5(1):7–13. doi: 10.1111/jtm.1998.5.issue-1.
   PubMedGoogle Scholar
• Takahashi TT, Vengeliene V, Spanagel R. 2017. Melatonin reduces motivation for cocaine self-administration and prevents relapse-like behavior in rats. Psychopharmacology (Berl). 234(11):1741–1748. doi: 10.1007/s00213-017-4576-y.
   PubMed Web of Science ®Google Scholar
• Toma CD, Svoboda M, Arrich F, Ekmekcioglu C, Assadian O, Thalhammer T. 2007. Expression of the melatonin receptor (MT) 1 in benign and malignant human bone tumors. J Pineal Res. 43(2):206–213. doi: 10.1111/jpi.2007.43.issue-2.
   PubMed Web of Science ®Google Scholar
• Turkistani A, Abdullah KM, Al-Shaer AA, Mazen KF, Alkatheri K. 2007. Melatonin premedication and the induction dose of propofol. Eur J Anaesthesiol. 24(5):399–402. doi: 10.1017/S0265021506001505.
   PubMed Web of Science ®Google Scholar
• Wang F, Li J, Wu C, Yang J, Xu F, Zhao Q. 2003a. The GABAA receptor mediates the hypnotic activity of melatonin in rats. Pharmacol Biochem Behav. 74(3):573–578. doi: 10.1016/S0091-3057(02)01045-6.
   PubMed Web of Science ®Google Scholar
• Wang F, Li J-C, Wu C-F, Yang J-Y, Xu F, Peng F. 2002. Hypnotic activity of melatonin: involvement of semicarbazide hydrochloride, blocker of synthetic enzyme for GABA. Acta Pharmacol Sin. 23(9):860–864.
   PubMed Web of Science ®Google Scholar
• Wang F, Li JC, Wu CF, Yang JY, Zhang RM, Chai HF. 2003b. Influences of a light-dark profile and the pineal gland on the hypnotic activity of melatonin in mice and rats. J Pharm Pharmacol. 55(9):1307–1312. doi: 10.1211/0022357021729.
   PubMed Web of Science ®Google Scholar
• Wu Y-H, Ursinus J, Zhou J-N, Scheer FA, Ai-Min B, Jockers R, van Heerikhuize J, Swaab DF. 2013. Alterations of melatonin receptors MT1 and MT2 in the hypothalamic suprachiasmatic nucleus during depression. J Affect Disord. 148(2–3):357–367. doi: 10.1016/j.jad.2012.12.025.
   PubMed Web of Science ®Google Scholar
• Yi X-Y, Ni S-F, Ghadami MR, Meng H-Q, Chen M-Y, Kuang L, Zhang Y-Q, Zhang L, Zhou X-Y. 2018. Trazodone for the treatment of insomnia: a meta-analysis of randomized placebo-controlled trials. Sleep Med. 45:25–32. doi: 10.1016/j.sleep.2018.01.010.
   PubMed Web of Science ®Google Scholar
• Zlotos DP, Jockers R, Cecon E, Rivara S, Witt-Enderby PA. 2014. MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential. J Med Chem. 57(8):3161–3185. doi: 10.1021/jm401343c.
   PubMed Web of Science ®Google Scholar